Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity
Wassarman, D.R., Pfaff, P., Paulo, J.A., Gygi, S.P., Shokat, K.M., Kranzusch, P.J.(2025) Science 
Experimental Data Snapshot
Starting Model: in silico
View more details
(2025) Science 
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Cap10 | 332 | Hyphomicrobiales | Mutation(s): 0  | ![]() | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
CdnD | C [auth G], D [auth H] | 320 | Hyphomicrobiales | Mutation(s): 0  | ![]() |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 2 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
COA Query on COA | E [auth G], G [auth H] | COENZYME A C21 H36 N7 O16 P3 S RGJOEKWQDUBAIZ-IBOSZNHHSA-N | |||
2KA (Subject of Investigation/LOI) Query on 2KA | F [auth G], H | 2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid C7 H6 N4 O3 XIUIRSLBMMTDSK-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 70.459 | α = 90 |
b = 82.92 | β = 90 |
c = 231.779 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
Coot | model building |
AutoProcess | data processing |
XDS | data reduction |
Aimless | data scaling |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) | United States | 1DP2GM146250-01 |